Envoy Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-29.91	-15.92	-10.68
Depreciation & Amortization	0.13	0.08	0.07
Share-Based Compensation	1.58	0	0
Other Operating Activities	10.55	7.04	1.67
Operating Cash Flow	-17.65	-8.81	-6.94
Capital Expenditures	-0.15	-0.22	-0.13
Investing Cash Flow	-0.15	-0.22	-0.13
Share Issuance / Repurchase	11.85	0	0
Debt Issued / Paid	10	8	8
Other Financing Activities	-	0.09	0.06
Financing Cash Flow	21.85	8.09	8.06
Exchange Rate Effect	-0	-0.01	-0.01
Net Cash Flow	4.04	-0.94	0.99
Free Cash Flow	-17.81	-9.02	-7.06
Free Cash Flow Margin	-5635.13%	-3807.17%	-2277.74%
Free Cash Flow Per Share	-1.42	-0.89	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).